Clinical Trial Update: Open Label Extension [Phase 3]

View source ↗

Summary

Open-label extension update for a Phase 3 osteoporosis trial; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Snippet

Sponsor: Shire | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED